Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

NowPatient vs Sumbare Wellness

NowPatient
Graded #222

Higher grade

vs+3.6000000000000014
Sumbare Wellness
Graded #283

Lower grade

The verdict

NowPatient takes it — 65.5/100 to 61.9/100.

NowPatient grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. NowPatient is a US-UK telehealth platform offering brand-name GLP-1 weight management access including Mounjaro, Wegovy (injection and oral tablet), and Saxenda.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueSumbare Wellness +31
35
66
Dose & formulationNowPatient +21
93
72
Clinical oversightNowPatient +30
86
56
Labs & monitoringNowPatient +2
54
52
FulfillmentNowPatient +11
70
59
Contract termsSumbare Wellness +6
55
61
NowPatient · left barSumbare Wellness · right bar

The numbers

MetricNowPatientSumbare Wellness
WeighScore65.5/10061.9/100
GradeCC
Scorecard rank#222#283
Semaglutide$1,349/mo (brand Wegovy)$199/mo (all doses, compounded)
Tirzepatide$1,069/mo (brand Mounjaro, promotional rate)$199/mo (all doses, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualYesInjection only
NowPatient

Graded #222 · C

Strengths

  • Free telehealth consultation — you only pay for the medication
  • Brand-name Mounjaro, Wegovy injection, Wegovy oral tablet, and Saxenda all available
  • One of the few platforms offering Wegovy in both injection and oral pill form
  • No compounded options — every drug is FDA-approved brand-name

Where it loses points

  • Cash-pay pricing tracks full brand list price (~$1,000–$1,350/mo)
  • No compounded semaglutide or tirzepatide (usually the cheaper route)
  • State availability determined during intake, not shown upfront
  • Does not offer Foundayo (orforglipron)
Sumbare Wellness

Graded #283 · C

Strengths

  • One flat $199/month price covering medication, provider review and shipping, with no consultation fee and no dose-change surcharge
  • Charges nothing if a provider does not approve you
  • Offers a deliberate low-dose microdosing protocol aimed at body composition, which most competitors do not break out
  • Publishes a named legal entity, a US mailing address and a working phone number
  • Pre-screening quiz is short and asks your goal before any medical question

Where it loses points

  • Cancellation terms contradict three ways: the homepage says cancel anytime, the Terms say 48 hours notice, the FAQ says 30 days
  • Availability is unclear: the homepage counter reads 3 states while the treatment pages say telehealth nationwide, and no state list is published
  • Its chart cites placebo-controlled trials of compounded semaglutide and tirzepatide, which do not exist; those trials studied the branded drugs
  • No compounding pharmacy is named, and neither 503A nor 503B appears anywhere on the site
  • Any returned prescription is charged a $35 disposal fee, and prescription orders cannot be cancelled at all after 24 hours

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard